1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide

C115H152F6N16O18Si2 — CID 160996654

IUPAC1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide
SMILESCC(=O)C1(C(=O)O)CC1.CC(=O)N1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.CC(C)(C)OC(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O.CN1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.COC(=O)[C@@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)OC(C)(C)C.O=C(Nc1cc2c(/C=C/c3ccc(F)cc3)n[nH]c2cc1F)C1(CN2CCC(O)CC2)CC1
InChIInChI=1S/C26H27F2N5O2.C25H27F2N5O.C25H26F2N4O2.C17H33NO5Si.C16H31NO5Si.C6H8O3/c1-17(34)33-12-10-32(11-13-33)16-26(8-9-26)25(35)29-24-14-20-22(30-31-23(20)15-21(24)28)7-4-18-2-5-19(27)6-3-18;1-31-10-12-32(13-11-31)16-25(8-9-25)24(33)28-23-14-19-21(29-30-22(19)15-20(23)27)7-4-17-2-5-18(26)6-3-17;26-17-4-1-16(2-5-17)3-6-21-19-13-23(20(27)14-22(19)30-29-21)28-24(33)25(9-10-25)15-31-11-7-18(32)8-12-31;1-16(2,3)22-15(20)18-11-12(10-13(18)14(19)21-7)23-24(8,9)17(4,5)6;1-15(2,3)21-14(20)17-10-11(9-12(17)13(18)19)22-23(7,8)16(4,5)6;1-4(7)6(2-3-6)5(8)9/h2-7,14-15H,8-13,16H2,1H3,(H,29,35)(H,30,31);2-7,14-15H,8-13,16H2,1H3,(H,28,33)(H,29,30);1-6,13-14,18,32H,7-12,15H2,(H,28,33)(H,29,30);12-13H,10-11H2,1-9H3;11-12H,9-10H2,1-8H3,(H,18,19);2-3H2,1H3,(H,8,9)/b2*7-4+;6-3+;;;/t;;;12-,13+;11-,12+;/m...11./s1
InChIKeyTVIJDYGKDGYBCZ-KAFRHQPOSA-N
MW2216.73 g/mol
LogP19.53
Rot. Bonds26

About 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide

1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide (PubChem CID 160996654) has the molecular formula C115H152F6N16O18Si2 and a molecular weight of 2216.73 g/mol. Its IUPAC name is 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide.

Molecular Properties

Compound Name1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide
PubChem CID160996654
Molecular FormulaC115H152F6N16O18Si2
Molecular Weight2216.73 g/mol
Exact Mass2215.09
IUPAC Name1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide
SMILESCC(=O)C1(C(=O)O)CC1.CC(=O)N1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.CC(C)(C)OC(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O.CN1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.COC(=O)[C@@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)OC(C)(C)C.O=C(Nc1cc2c(/C=C/c3ccc(F)cc3)n[nH]c2cc1F)C1(CN2CCC(O)CC2)CC1
InChIInChI=1S/C26H27F2N5O2.C25H27F2N5O.C25H26F2N4O2.C17H33NO5Si.C16H31NO5Si.C6H8O3/c1-17(34)33-12-10-32(11-13-33)16-26(8-9-26)25(35)29-24-14-20-22(30-31-23(20)15-21(24)28)7-4-18-2-5-19(27)6-3-18;1-31-10-12-32(13-11-31)16-25(8-9-25)24(33)28-23-14-19-21(29-30-22(19)15-20(23)27)7-4-17-2-5-18(26)6-3-17;26-17-4-1-16(2-5-17)3-6-21-19-13-23(20(27)14-22(19)30-29-21)28-24(33)25(9-10-25)15-31-11-7-18(32)8-12-31;1-16(2,3)22-15(20)18-11-12(10-13(18)14(19)21-7)23-24(8,9)17(4,5)6;1-15(2,3)21-14(20)17-10-11(9-12(17)13(18)19)22-23(7,8)16(4,5)6;1-4(7)6(2-3-6)5(8)9/h2-7,14-15H,8-13,16H2,1H3,(H,29,35)(H,30,31);2-7,14-15H,8-13,16H2,1H3,(H,28,33)(H,29,30);1-6,13-14,18,32H,7-12,15H2,(H,28,33)(H,29,30);12-13H,10-11H2,1-9H3;11-12H,9-10H2,1-8H3,(H,18,19);2-3H2,1H3,(H,8,9)/b2*7-4+;6-3+;;;/t;;;12-,13+;11-,12+;/m...11./s1
InChIKeyTVIJDYGKDGYBCZ-KAFRHQPOSA-N
XLogP19.53
TPSA422.35 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds26
Heavy Atoms157
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002216.73
LogP ≤ 519.53
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide?
The IUPAC name of 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide (CID 160996654) is 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide.
What is the SMILES notation for 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide?
The canonical SMILES for 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide is CC(=O)C1(C(=O)O)CC1.CC(=O)N1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.CC(C)(C)OC(=O)N1C[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)O.CN1CCN(CC2(C(=O)Nc3cc4c(/C=C/c5ccc(F)cc5)n[nH]c4cc3F)CC2)CC1.COC(=O)[C@@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)OC(C)(C)C.O=C(Nc1cc2c(/C=C/c3ccc(F)cc3)n[nH]c2cc1F)C1(CN2CCC(O)CC2)CC1.
What is the InChIKey of 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide?
The InChIKey is TVIJDYGKDGYBCZ-KAFRHQPOSA-N. The full InChI is InChI=1S/C26H27F2N5O2.C25H27F2N5O.C25H26F2N4O2.C17H33NO5Si.C16H31NO5Si.C6H8O3/c1-17(34)33-12-10-32(11-13-33)16-26(8-9-26)25(35)29-24-14-20-22(30-31-23(20)15-21(24)28)7-4-18-2-5-19(27)6-3-18;1-31-10-12-32(13-11-31)16-25(8-9-25)24(33)28-23-14-19-21(29-30-22(19)15-20(23)27)7-4-17-2-5-18(26)6-3-17;26-17-4-1-16(2-5-17)3-6-21-19-13-23(20(27)14-22(19)30-29-21)28-24(33)25(9-10-25)15-31-11-7-18(32)8-12-31;1-16(2,3)22-15(20)18-11-12(10-13(18)14(19)21-7)23-24(8,9)17(4,5)6;1-15(2,3)21-14(20)17-10-11(9-12(17)13(18)19)22-23(7,8)16(4,5)6;1-4(7)6(2-3-6)5(8)9/h2-7,14-15H,8-13,16H2,1H3,(H,29,35)(H,30,31);2-7,14-15H,8-13,16H2,1H3,(H,28,33)(H,29,30);1-6,13-14,18,32H,7-12,15H2,(H,28,33)(H,29,30);12-13H,10-11H2,1-9H3;11-12H,9-10H2,1-8H3,(H,18,19);2-3H2,1H3,(H,8,9)/b2*7-4+;6-3+;;;/t;;;12-,13+;11-,12+;/m...11./s1.
What are the key properties of 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide?
1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide has a molecular weight of 2216.73 g/mol, XLogP of 19.53, 26 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 1-acetylcyclopropane-1-carboxylic acid;1-[(4-acetylpiperazin-1-yl)methyl]-N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]cyclopropane-1-carboxamide;(2S,4R)-4-[tert-butyl(dimethyl)silyl]oxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid;1-O-tert-butyl 2-O-methyl (2S,4R)-4-[tert-butyl(dimethyl)silyl]oxypyrrolidine-1,2-dicarboxylate;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-hydroxypiperidin-1-yl)methyl]cyclopropane-1-carboxamide;N-[6-fluoro-3-[(E)-2-(4-fluorophenyl)ethenyl]-1H-indazol-5-yl]-1-[(4-methylpiperazin-1-yl)methyl]cyclopropane-1-carboxamide is sourced from PubChem (CID 160996654), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).